Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
09/2005
09/22/2005US20050208631 Polypeptide of N-acetylglucosamine-6-O-sulfotransferase and DNA encoding the same
09/22/2005US20050208629 Plasmids for polyketide production
09/22/2005US20050208628 Methods and vectors for generating antibodies in avian species and uses therefor
09/22/2005US20050208623 Expression of granular starch hydrolyzing enzyme in Trichoderma
09/22/2005US20050208620 Nucleic acid sequence encoding epothilone B hydroxylase and recombinent microorganisms containing the sequence
09/22/2005US20050208619 29 human secreted proteins
09/22/2005US20050208618 Nucleotide sequences coding thrombospondin metalloproteinase-like-thrombospondin type 1 (ITGL-TSP) protein for identifying modulators to treat and prevent diabetes, restenosis, alzheimer's, cell proliferative and cardiovascular disorders
09/22/2005US20050208617 Human-like glycoproteins; for hydrolysis of oligosaccharide substrates for N-glycan processing in secretory pathway
09/22/2005US20050208613 Common ligand universal enzyme assay and compositions for use therein
09/22/2005US20050208611 Process for identifying compounds with fungicide activity based on UMP/CMP kinases from fungi
09/22/2005US20050208604 An amphetamine and a methamphetamine group linked by a linking group, a polyamino acid or a nonpolyamino acid label linked to a second linking group which is attached to first linking group at a equidistance from both drugs, and second linking group terminates in a functional group; antiboides; sample
09/22/2005US20050208603 Using enzyme complexes; forming antibodies; measuring signals; calibration
09/22/2005US20050208601 Using f-box containing protein as tool in treatment and prevention of infection, cardiovascular, cell proliferative and nervous system disorders
09/22/2005US20050208581 Heat resistant polymerase for use in cyclic DNA amplification
09/22/2005US20050208578 Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
09/22/2005US20050208571 Nucleotide sequences coding animal hydrolases for use in identifying modulators for prevention and treatment of physiological disorders; drug screening
09/22/2005US20050208566 Using enzymatic membrane protein as tool in identifying modulators for prevention and treatment of atherosclerotic, inflammatory and cell proliferative disorders
09/22/2005US20050208560 Using immunoglobulins to identify staphylococcal peptides associated with viriginiamycin resistant
09/22/2005US20050208559 directed toward modulating oxidative damage to intracellular components such as mitochondrial DNA (mtDNA) and mitochondrial protein; antibody, or fragment thereof, that specifically binds to enzyme
09/22/2005US20050208552 Corpuscles of Stannius protein, stanniocalcin
09/22/2005US20050208544 Diagnostic tests for the detection of peripheral neuropathy
09/22/2005US20050208536 Comprises ribonuclease barnase marker gene; libraries; drug resistance
09/22/2005US20050208524 Full-length expressed genetic marker (FLEXGEM) polypeptide for use as diagnostic indicator of cell proliferative disorders
09/22/2005US20050208523 Compositions and methods for the diagnosis and treatment of tumor
09/22/2005US20050208520 Polynucleotide sequences encoding alkaline alpha-galactosidases and methods of using same
09/22/2005US20050208508 Gene encoding labyrinthin, a marker for cancer
09/22/2005US20050208507 Human RPS6KA6-related gene variant associated with lung cancers
09/22/2005US20050208497 Yeast regulatory sequences comprising genetic suppressor elements for use as tool in controlling expression of heterologous genes
09/22/2005US20050208492 Regulation of human serine/threonine kinase
09/22/2005US20050208489 Targeted chromosomal mutagenasis using zinc finger nucleases
09/22/2005US20050208484 Isolated nucleic acid molecules encoding human drugmetobolizing proteins
09/22/2005US20050208178 Microbially expressed xylanases and their use as feed additives and other uses
09/22/2005US20050208155 New DNA polymerase inhibitors, mikanolide and dihydromikanolide
09/22/2005US20050208063 Vaccine containing a thiol protease
09/22/2005US20050208055 Monoclonal antibodies; hybridoma cell lines; for use in Western blot analysis, immunohistochemisty, protein purification; diagnosis of cancer and vitamin D metabolic conditions; drug screening
09/22/2005US20050208050 Compounds for the diagnosis/prevention/treatment of alzheimer's disease
09/22/2005US20050208021 Methods of unidirectional, site-specific integration into a genome, compositions and kits for practicing the same
09/22/2005US20050205489 Positioned upstream of system inlet, reduces presence of non specific binding species; hydrophobic, lipophilic, activated carbon, cations, anions, ligands; fumed silica, glass; fibers, beads, membranes; affinity chromatography columns, ultrafiltration systems
09/22/2005CA2559550A1 Thiol methyltransferase-based selection
09/22/2005CA2559164A1 Fungal lipolytic enzymes
09/22/2005CA2559124A1 Novel phosphorylated sequences of phosphatase cdc25b, antibodies directed against said sequences and use thereof
09/22/2005CA2559060A1 Phospholipases, nucleic acids encoding them and methods for making and using them
09/22/2005CA2559055A1 Modified oncolytic viruses
09/22/2005CA2558984A1 Recombinant chondroitinase abc i and uses thereof
09/22/2005CA2558815A1 Barley for production of flavor-stable beverage
09/22/2005CA2558213A1 Crystal structure of 3',5'-cyclic nucleotide phosphodiesterase (pde10a) and uses thereof
09/22/2005CA2557578A1 Novel xylanases and their use
09/22/2005CA2541177A1 Vectors for directional cloning
09/22/2005CA2476028A1 Novel purified polypeptides from staphylococcus pneumoniae
09/21/2005EP1577382A2 Detection of TSE infectivity
09/21/2005EP1577319A1 Prefilter system for biological systems
09/21/2005EP1576967A1 Recombinant protein, carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof, therapeutic uses thereof
09/21/2005EP1576964A1 Protease inhibitor
09/21/2005EP1576370A2 Methods of diagnosing and treating diabetes and insulin resistance
09/21/2005EP1576175A2 Vascular-preferred promoters
09/21/2005EP1576166A2 Novel method for the production of polyunsaturated fatty acids
09/21/2005EP1576165A2 Methods for increasing total oil levels in plants
09/21/2005EP1576164A2 Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content
09/21/2005EP1576161A1 A salt tolerant l-myo-inositol 1 phosphate synthase and the process of obtaining the same
09/21/2005EP1576159A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
09/21/2005EP1576153A2 Device and process for the preparation of autologous thrombin serum
09/21/2005EP1576152A1 Thermostable alpha-amylases
09/21/2005EP1576151A2 Ap1 amine oxidase variants
09/21/2005EP1576142A2 Identification of oligoadenylate synthetase-like genes
09/21/2005EP1576139A2 Dep-1 receptor protein tyrosine phosphatase interacting proteins and related methods
09/21/2005EP1576137A2 Compositions and methods for the treatment of immune related diseases
09/21/2005EP1576133A2 Casein kinase i epsilon and casein kinase i delta and sleep in humans
09/21/2005EP1576129A2 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
09/21/2005EP1576128A2 Products and processes for modulating peptide-peptide binding domain interactions
09/21/2005EP1576127A2 Crystalline form of fatty acid amine hydrolase (faah)
09/21/2005EP1576114A2 Compositions and methods for controlling parasitic nematodes
09/21/2005EP1576108A2 Nitrilases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576106A2 Process and materials for production of glucosamine and n-acetylglucosamine
09/21/2005EP1576102A2 Amidases, nucleic acids encoding them and methods for making and using them
09/21/2005EP1576099A2 Novel polynucleotides encoding the human citron kinase polypeptide, bmsnkc 0020/0021
09/21/2005EP1576096A2 N-ACETYLGLUCOSAMINYLTRANSFERASE Vb CODING SEQUENCE, RECOMBINANT CELLS AND METHODS
09/21/2005EP1576095A2 Fatty alcohol oxidase genes and proteins from candida troplicalis and methods relating thereto
09/21/2005EP1576087A2 Method for detecting remote homologues and kinases identified with the method
09/21/2005EP1576086A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/21/2005EP1576010A2 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix
09/21/2005EP1576007A2 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders
09/21/2005EP1575992A2 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
09/21/2005EP1575881A2 Alanine 2,3- aminomutase
09/21/2005EP1575548A2 Compositions and methods for promoting neuronal outgrowth
09/21/2005EP1575534A2 D4,5 glycuronidase and uses thereof
09/21/2005EP1575518A2 Compositions, organisms and methodologies employing a novel human kinase
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1575482A2 Compositions and method of treating alzheimer's disease
09/21/2005EP1534819A4 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
09/21/2005EP1499177A4 Transgenic plants with a suppressed triterpene level
09/21/2005EP1313870B1 Method for the improved production and isolation of trans-dihydroxycyclohexadiene carboxylic acids and/or derivatives thereof and a genetically modified organism suitable for the above
09/21/2005EP1305420A4 Modification of fructan biosynthesis
09/21/2005EP1129188B1 Pge synthase and methods and means for modulating its activity
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP1027371B1 Process for the production of highly viral safe thrombin for forming fibrin glue from a pool of human plasma
09/21/2005EP1019533B1 Silanol enzyme inhibitors
09/21/2005EP1002065B1 Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations
09/21/2005EP0974057B1 Methods to detect hk2 polypeptides
09/21/2005EP0793721B1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
09/21/2005EP0792364B1 Lgmd gene coding for a calcium dependent protease
1 ... 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 ... 1416